Skip to main content

Cypress Wealth Services, LLC

Position in NVS — Novartis AG

CIK 1721527 PALM DESERT, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$305,290
-$15,332 QoQ
Shares Held
1,948
-7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,122
of 1,603 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Sep 30, 2020
CallValue
$0
CallShares
0
PutValue
$226,009
PutShares
2,599

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Cypress Wealth Services, LLC holds $11,046,783 across 9 Drug Manufacturers - General names. NVS ranks #9 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $305,290 1,948
2026-03-31 $320,622 2,099
2025-12-31 $359,289 2,606
2025-09-30 $272,638 2,126
2025-06-30 $256,783 2,122
2025-03-31 $221,176 1,984
2024-09-30 $212,787 1,850
2024-03-31 $201,585 2,084
2021-03-31 $209,938 2,456
2020-12-31 $223,138 2,363
2020-09-30 $226,009 2,599